期刊文献+

肿瘤标志物联合检测在胰腺癌诊断和疗效评价中的作用 被引量:4

The clinical significance of combined detection of serum tumor markers levels in diagnosis and therapeautic evaluation of pancreatic carcinoma
暂未订购
导出
摘要 目的探讨CA199、CA242、CA125、CEA和OPN联合检测对胰腺癌诊断和疗效评价的临床价值。方法检测41胰腺癌患者术前及术后1个月和40例健康体检者外周血清中肿瘤标志物CA199、CA242、CA125、CEA和OPN的水平,比较胰腺癌组术前和术后的变化。并计算肿瘤标志物诊断胰腺癌的敏感性、特异性及准确性。结果胰腺癌组各肿瘤标志物测定值及阳性率明显高于正常对照组,术前测定值明显高于术后,差异有统计学意义,P均<0.05。标志物联合检测的敏感性和诊断准确性均比单项检测高,其中单项以CA199敏感性最高。结论 CA199、CA242、CA125、CEA和OPN联合检测对胰腺癌的诊断、疗效观察及复发预测是较理想的指标,具有重要的临床意义。 Objective To explore the clinical significance of combined detection of serum CA199,CA242,CA125 ,CEA and OPN levels in diagnosis and therapeautic evaluation of pancreatic carcinoma. Methods Detection of Serum tumor markers CA199,CA242,CA125 ,CEA and OPN Were carried out in 41 patients with pancreatic carcinoma and 40 healthy volunteer, and in pancreatic cancer group these tumor markers were detect- ed before operation and 1 month after operation. The sensitivity, specificity and accuracy of the detection in pancreatic cancer diagnosis were calcu- lated. Results The concerntrations of these tumor markers and the positive ratio in the patients with pancreatic cancer were significantly higher than those in the normal controls, The concentrations of the five markers of preoperation are higher than that of postoperation, and difference was sta- tistically significant (all P〈0.05). If serum CA199, CA242, CA125, CEA and OPN were detected simultaneously, the sensitivity and specificity in di- agnosis of pancreatic cancer could be improved,and sensitivity of CA199 is the highest among those markers. Conclusion The combined detection of serum CA199, CA242, CA125, CEA and OPN levels has better clinical value in diagnosis, therapeutic effect evaluation and prognosis prediction.
出处 《浙江创伤外科》 2012年第3期294-297,共4页 Zhejiang Journal of Traumatic Surgery
关键词 肿瘤标志物 胰腺癌 诊断 疗效评价 Tumor markers Pancreatic carcinoma
  • 相关文献

参考文献8

二级参考文献152

共引文献79

同被引文献32

  • 1Mclaughlin R,Hanlon D,Kerin M,et al.Are elevated levels of the tumour marker CA19- 9 of any clinical significance-an evaluation[J].Ir J Med Sci,1999;168(2): 124-126.
  • 2Simeone DM,Ji B,Banerjee M,et aI.CEACAMI,a novel serum biomarker for pancreatic cancer[J].Pancreas,2007:36:436-443.
  • 3Obrink B.On the role of CEACAM1 in cancer[J].Lung Cancer,2008;60(3):309-312.
  • 4Samsen A,Bogoevska V, Klampe B,et aI.DC-SIGN and SRCL bind glycans of carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1):recombinant human glycanbinding receptors as analytical tools[J]. Ettr J Cell Biol,2010;89(1):87-94.
  • 5Chaturvedi P, Singh AP.Moniaux N,et aI.MUC4 potentiates pancreatic tumor cell proliferation,survival,and invasive properties and interikres with its interaction to extracellular matrix proteins[J].Mol Cancer Res,2007;5(4):309-320.
  • 6Ji B,Tsou L,Wang H,et al.Rasactivity Levels control the development of pancreatic diseases[J].Gastr oenter ology,2009;137(1): 1072-1082.
  • 7Ohuchida K,Mizumoto K,Yamada D,et al.Quantit ative analysis of human telomem sereverse Wanscriptase in pancreatic cancer[J].Clin Cancer Res,2006; 12( 1 ):2066-2069.
  • 8Greer JB, Brand RE. New developments in pancreatic cancer[J]. Curt Gastroenterol Rep, 2011, 13 ( 2 ) : 131- 139.
  • 9Bauskin AR,Brown DA, Kuffner T, et al. Role of macro- phage inhibitory cytokine-1 in tumor igenesis and diagno- sis of cancer[J]. Cancer Res, 2006,66 (10) : 4983-4986.
  • 10汤厚阔,陈炯.肿瘤标志物CA19-9、CA242、CEA和CA125联合检测在胰腺癌诊断中的意义[J].肝胆胰外科杂志,2009,21(2):95-97. 被引量:30

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部